2Fang WL, Wu CW, Chen JH, et al. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan. Ann Surg Oncol, 2009, 16:3237-3244.
3Zhang M, Li Z, Ma Y, et al. Prognostic predictors of patients with carcinoma of the gastric cardia. Hepatogastroenterology, 2012, 59:930-933.
4Lagarde SM, Reitsma JB, Ten Kate FJ, et al. Predictingindividual survival after potentially curative esophagectomy for adenocarcinoma of the esophagus or gastroesophageal junction. Ann Surg, 2008, 248 : 1006-1013.
5Eom BW, Yoon H, Ryu KW, et al. Predictors of timing and patterns of recurrence after curative resection for gastric cancer. Dig Surg, 2010, 27:481-486.
6Li F, Zhang R, Liang H, et al. The pattern and risk factors of recurrence of proximal gastric cancer after curative resection. J Surg Oncol, 2013, 107 : 130-135.
7Otsuji E, Kuriu Y, Ichikawa D, et al. Time to death and pattern of death in recurrence following curative resection of gastric carcinoma: analysis based on depth of invasion. World J Surg, 2004, 28:866-869.
8Abate E, DeMeester SR, Zehetner J, et al. Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing. J Am Coll Surg, 2010, 210:428-435.
9Spizzo G, Ofner D, de Vries A, et al. Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma:results from a phase l] feasibility study. Ann Surg Oncol, 2011, 18:677 4583.
10Newman E, Potmesil M, Ryan T, et al. Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase 1I study. Semin Oncol, 2005, 32: S97-100.
